文献速递糖尿病肥胖与代谢综合征

脂联素受体激动剂AdipoRon改善饮食诱导肥胖小鼠及内毒素处理人肾小球的肾脏炎症

Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo.
PubMed 文献 · Diabetologia · 2021-05-14

该研究在高脂饮食喂养的DBA/2J小鼠和LPS刺激的人肾小球及足细胞中,探讨AdipoRon的抗炎和肾脏保护作用。AdipoRon减轻了小鼠肾小球炎症标志物表达和形态损伤,并抑制LPS诱导的足细胞炎症信号通路激活、凋亡和迁移,减少人肾小球炎症因子分泌。结论提示激活脂联素受体可减轻内毒素血症相关肾脏炎症。

要点

  • AdipoRon降低HFD小鼠肾小球NF-κB-p65、TNFα、IL-1β、TGFβ表达及巨噬细胞浸润。
  • AdipoRon改善HFD诱导的肾小球肥大、纤连蛋白积聚和足细胞丢失。
  • AdipoRon抑制LPS诱导的足细胞NF-κB-p65、JNK和p38-MAPK激活及TNFα分泌。

核心结论

  • AdipoRon通过激活脂联素受体减轻内毒素血症相关肾脏炎症,可能为肥胖相关肾损伤提供治疗策略。

研究设计与样本

  • 野生型DBA/2J小鼠接受高脂饮食并补充或不补充AdipoRon,评估肾小球形态和促炎标志物表达。
  • 人肾小球离体和人间充质足细胞体外用AdipoRon和LPS处理,分析炎症因子分泌、信号通路激活、凋亡和迁移。

主要发现

  • HFD小鼠中AdipoRon降低肾小球NF-κB-p65(70%,p<0.001)、TNFα(48%,p<0.01)、IL-1β(51%,p<0.001)、TGFβ(46%,p<0.001)表达。
  • AdipoRon降低肾脏IL-6和IL-4(分别21%和20%,p<0.05)及肾小球F4/80阳性巨噬细胞浸润(31%,p<0.001)。
  • AdipoRon改善HFD诱导的肾小球肥大(12%,p<0.001)、纤连蛋白积聚(50%,p<0.01)、足细胞丢失(12%,p<0.001)、足突消失(15%,p<0.001)和基底膜增厚(18%,p<0.001)。
  • 培养足细胞中AdipoRon减弱LPS诱导的NF-κB-p65、JNK和p38-MAPK激活(分别30%、36%和22%,p<0.001),减少TNFα分泌(32%,p<0.01)。
  • 人肾小球离体中AdipoRon减少LPS诱导的IL-1β、IL-18、IL-6和IL-10分泌。

临床怎么用

  • AdipoRon可能作为减轻肥胖及内毒素血症相关肾脏炎症的潜在药物,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Chronic low-grade inflammation with local upregulation of proinflammatory molecules plays a role in the progression of obesity-related renal injury. Reduced serum concentration of anti-inflammatory adiponectin may promote chronic inflammation. Here, we investigated the potential anti-inflammatory and renoprotective effects and mechanisms of action of AdipoRon, an adiponectin receptor agonist. METHODS: Wild-type DBA/2J mice were fed with high-fat diet (HFD) supplemented or not with AdipoRon to model obesity-induced metabolic endotoxaemia and chronic low-grade inflammation and we assessed changes in the glomerular morphology and expression of proinflammatory markers. We also treated human glomeruli ex vivo and human podocytes in vitro with AdipoRon and bacterial lipopolysaccharide (LPS), an endotoxin upregulated in obesity and diabetes, and analysed the secretion of inflammatory cytokines, activation of inflammatory signal transduction pathways, apoptosis and migration. RESULTS: In HFD-fed mice, AdipoRon attenuated renal inflammation, as demonstrated by reduced expression of glomerular activated NF-κB p65 subunit (NF-κB-p65) (70%, p < 0.001), TNFα (48%, p < 0.01), IL-1β (51%, p < 0.001) and TGFβ (46%, p < 0.001), renal IL-6 and IL-4 (21% and 20%, p < 0.05), and lowered glomerular F4/80-positive macrophage infiltration (31%, p < 0.001). In addition, AdipoRon ameliorated HFD-induced glomerular hypertrophy (12%, p < 0.001), fibronectin accumulation (50%, p < 0.01) and podocyte loss (12%, p < 0.001), and reduced podocyte foot process effacement (15%, p < 0.001) and thickening of the glomerular basement membrane (18%, p < 0.001). In cultured podocytes, AdipoRon attenuated the LPS-induced activation of the central inflammatory signalling pathways NF-κB-p65, c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38-MAPK) (30%, 36% and 22%, respectively, p < 0.001), reduced the secretion of TNFα (32%, p < 0.01), and protected against podocyte apoptosis and migration. In human glomeruli ex vivo, AdipoRon reduced the LPS-induced secretion of inflammatory cytokines IL-1β, IL-18, IL-6 and IL-10. CONCLUSIONS/INTERPRETATION: AdipoRon attenuated the renal expression of proinflammatory cytokines in HFD-fed mice and LPS-stimulated human glomeruli, which apparently contributed to the amelioration of glomerular inflammation and injury. Mechanistically, based on assays on cultured podocytes, AdipoRon reduced LPS-induced activation of the NF-κB-p65, JNK and p38-MAPK pathways, thereby impelling the decrease in apoptosis, migration and secretion of TNFα. We conclude that the activation of the adiponectin receptor by AdipoRon is a potent strategy to attenuate endotoxaemia-associated renal inflammation.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Lindfors S, Polianskyte-Prause Z, Bouslama R, et al. Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo. Diabetologia. 2021. PMID: 33987714. doi:10.1007/s00125-021-05473-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。